Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur urol 2006;49:54-8. - Suppr | 超能文献

Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur urol 2006;49:54-8.

作者信息

Sharma R, Sundar S

出版信息

Eur Urol. 2007 Apr;51(4):1146. doi: 10.1016/j.eururo.2006.11.051. Epub 2006 Dec 4.

DOI:10.1016/j.eururo.2006.11.051

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur urol 2006;49:54-8.

Eur Urol. 2007 Apr;51(4):1146. doi: 10.1016/j.eururo.2006.11.051. Epub 2006 Dec 4.

2

Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur Urol 2006;49:54-58.

Eur Urol. 2007 Mar;51(3):864. doi: 10.1016/j.eururo.2006.06.030. Epub 2006 Jul 7.

3

Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leupoprolide acetate in locally advanced prostate cancer. Eur Urol 2006;49:54-8.

Eur Urol. 2006 Sep;50(3):626-7. doi: 10.1016/j.eururo.2006.04.017. Epub 2006 May 6.

4

Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer.

Eur Urol. 2006 Jan;49(1):54-8; discussion 58. doi: 10.1016/j.eururo.2005.09.009. Epub 2005 Nov 15.

5

Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer.

BJU Int. 2008 May;101(9):1096-100. doi: 10.1111/j.1464-410X.2007.07374.x. Epub 2008 Jan 8.

6

Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer.

Anticancer Res. 2005 Jan-Feb;25(1B):577-8.

7

Locally advanced prostate cancer--biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy.

Cancer. 2007 Mar 1;109(5):858-67. doi: 10.1002/cncr.22464.

8

Leuprorelin, triptorelin: new indications. Locally advanced prostate cancer: minimally assessed me-toos.

Prescrire Int. 2007 Dec;16(92):243.

9

Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain?

Expert Rev Anticancer Ther. 2005 Aug;5(4):605-11. doi: 10.1586/14737140.5.4.605.

10

Managing advanced prostate cancer with Viadur (leuprolide acetate implant).

Urol Nurs. 2001 Dec;21(6):385-8, 393-4; quiz 395-6.